rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Timothy Warbington

President & CEO

Company insider

Files Form 4 as: President & CEO, Creative Medical Technology Holdings.

Every Form 4 they filed

In numbers

Trades disclosed
40
Buys
9
Sells
7
Bought
$102K
Sold
$627K
Companies
1
Companies where not an officer
0
First trade
30 Sep 2016
Last trade
24 Sep 2026
Last filed
25 Sep 2026

Companies traded

Where they are an officer
CELZ Creative Medical Technology HoldingsDirector, Officer, 10% owner · Biotechnology · last 24 Sep 20269 buys · 7 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
24 Sep 2026filed 25 Sep 2026CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Code A—1,000,000filing
24 Sep 2026filed 25 Sep 2026CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Code A—1,000,000filing
28 Jun 2023filed 29 Jun 2023CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$872200 at $4.36filing
27 Jun 2023filed 29 Jun 2023CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$1,320300 at $4.40filing
27 Jun 2023filed 29 Jun 2023CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$1,335300 at $4.45filing
27 Jun 2023filed 29 Jun 2023CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$896200 at $4.48filing
22 Nov 2022filed 23 Nov 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$3,8229,800 at $0.39filing
22 Nov 2022filed 23 Nov 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$76200 at $0.38filing
21 Nov 2022filed 23 Nov 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$4,00010,000 at $0.40filing
21 Nov 2022filed 23 Nov 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$1,9505,000 at $0.39filing
27 Sep 2022filed 28 Sep 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$10K20,000 at $0.50filing
22 Sep 2022filed 22 Sep 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$6,48012,000 at $0.54filing
21 Sep 2022filed 22 Sep 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$3,0505,000 at $0.61filing
21 Sep 2022filed 22 Sep 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$2,8804,500 at $0.64filing
21 Sep 2022filed 22 Sep 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$315500 at $0.63filing
21 Sep 2022filed 22 Sep 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$12K20,000 at $0.61filing
6 Jun 2022filed 7 Jun 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$1,8402,000 at $0.92filing
6 Jun 2022filed 7 Jun 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$7,3608,000 at $0.92filing
6 Jun 2022filed 7 Jun 2022CELZ Creative Medical Technology HoldingsBiotechnologySEC FORM 4 Bought$14K15,000 at $0.91filing
9 Feb 2022filed 11 Feb 2022CELZ Creative Medical Technology Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—58,580 at $0.00filing

News

Creative Medical Technology Holdings Highlights 93% Patient Response Rate and 65% Reduction in Average Pain Scores in Ultrasome™ Knee Osteoarthritis StudyCELZ · manilatimes.net · 20 Oct 2026

0 headlines in the last 90 days name Timothy Warbington; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care16

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.